Document:

Consent and First Amendment

 Exhibit 10.2 
 March 30, 2012 
 Kforce Inc. 
 Kforce Government Solutions, Inc. 
 Kforce Clinical Research, Inc. 

Kforce Clinical Research Flex, LLC 
 Kforce
Healthcare, Inc. 
 Kforce Healthcare Flex, LLC 
 KCR Canada, Inc. 
 KCR Puerto Rico, LLC 
 kforce Airlines, Inc. 
 Kforce.com, Inc. 
 Kforce Flexible Solutions, LLC 
 Kforce Government Holdings Inc. 

Kforce Staffing Solutions of California, LLC 

Kforce Global Solutions, Inc. 
 Romac
International, Inc. 
 Kforce Services Corp. 
 1001 E. Palm Avenue, 4th Floor 
 Tampa, Florida 33605 

Attention: Judy M. Genshino-Kelly, Vice President and Treasurer 
  

	 	RE:	Consent and First Amendment to Third Amended and Restated Credit Agreement 

 Ladies and Gentlemen: 
 Reference is made to that certain Third Amended and
Restated Credit Agreement dated September 20, 2011 (as at any time amended, modified, restated, or supplemented, the “Credit Agreement”), by and among Kforce Inc., a Florida corporation (“Kforce”);
Kforce Government Solutions, Inc., a Pennsylvania corporation and successor by merger to Bradson Corporation and RDI Systems, Inc. (“Government Solutions”); Kforce Clinical Research, Inc., a Florida corporation
(“Clinical Research”); Kforce Clinical Research Flex, LLC, a Florida limited liability company (“Clinical Research Flex”); Kforce Healthcare, Inc., a Florida corporation
(“Healthcare”); Kforce Healthcare Flex, LLC, a Florida limited liability company (“Healthcare Flex”); KCR Canada, Inc., a Florida corporation (“KCR Canada”); and KCR Puerto Rico,
LLC, a Florida limited liability company (“KCR Puerto Rico”; Kforce, Government Solutions, Clinical Research, Clinical Research Flex, Healthcare, Healthcare Flex, KCR Canada, and KCR Puerto Rico are collectively referred to
herein as “Borrowers” and individually as a “Borrower”); kforce Airlines, Inc., a Florida corporation (“Airlines”); Kforce.com, Inc., a Florida corporation
(“Kforce.com”); Kforce Flexible Solutions, LLC, a Florida limited liability company (“Flexible Solutions”); Kforce Government Holdings Inc., a Florida corporation (“Government
Holdings”); Kforce Staffing Solutions of California, LLC, a Florida limited liability company (“Staffing Solutions”); Kforce Global Solutions, Inc., f/k/a Provident Computer Consultants, Inc. and a
Pennsylvania corporation (“Global Solutions”); Romac International, Inc., a Florida corporation (“Romac”); and Kforce Services Corp., a Florida corporation (“Kforce Services”;
Airlines, Kforce.com, Flexible Solutions, Government Holdings, Staffing Solutions, Global Solutions, Romac, and Kforce Services are collectively referred to herein as “Guarantors” and individually as a “Guarantor”;
Borrowers and Guarantors are collectively referred to herein as “Credit Parties” and individually as a “Credit Party”); and Bank of America, N.A., a national banking association, individually as a Lender and
the Letter of Credit Issuer and in its capacity as agent for Lenders (together 

 
with its successors and assigns in its capacity as agent, “Administrative Agent”); and the financial institutions from time to time parties thereto (such financial institutions,
together with their respective successors and assigns, are referred to hereinafter each individually as a “Lender” and collectively as “Lenders”). Capitalized terms used herein, unless otherwise defined herein,
shall have the meanings ascribed to such terms under the Credit Agreement. 
 Credit Parties have informed Administrative Agent
and Lenders that Kforce intends to enter into that certain Stock Purchase Agreement substantially in the form of Exhibit A attached hereto (the “SPA”; collectively with all other documents, instruments, agreements, and
certificates executed and delivered in connection therewith, the “Sale Documents”), among Kforce, inVentiv Health, Inc., a Delaware corporation (“Purchaser”), and Clinical Research, pursuant to which Kforce intends
to sell to Purchaser, and Purchaser intends to purchase from Kforce, all of the Capital Stock of Clinical Research and Clinical Research Flex, for an aggregate cash consideration that is equal to or greater than $49,640,000 (collectively, the
“Sale Proceeds”). Such sale transaction is collectively referred to herein as the “Clinical Research Sale Transaction.” 
 In connection with the Clinical Research Sale Transaction, Credit Parties have requested that Administrative Agent and Lenders enter into this letter amendment and consent to (x) release Clinical
Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico from their duties and obligations under the Credit Agreement and the other Loan Documents, and (y) release Administrative Agent’s Lien upon (i) the Capital Stock of
each of Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico, and (ii) the assets of each of Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico (the assets referred to in the foregoing subclauses
(i) and (ii) are collectively referred to herein as the “Released Assets”), in each case, upon consummation of the Clinical Research Sale Transaction. 

On the date of the proposed Clinical Research Sale Transaction and as a condition to the release requested hereunder, Borrowers will
certify to Administrative Agent and Lenders that the Clinical Research Sale Transaction is permitted under Section 7.9(b) of the Credit Agreement. 
 Credit Parties also have requested that Section 7.9(b) of the Credit Agreement be amended to permit the sale of not just assets of Borrowers but also assets of Guarantors, all in accordance
with Section 7.9(b) of the Credit Agreement. 
 Subject to the terms and conditions set forth herein, Administrative
Agent and Lenders are willing to enter into this letter amendment. 
 NOW, THEREFORE, in consideration of the mutual conditions
and agreements set forth in this letter amendment, and for good and valuable consideration, the receipt of which is hereby acknowledged, Lenders, Administrative Agent, and Credit Parties hereby agree as follows. 

1. Amendment to Credit Agreement. Upon satisfaction of each of the conditions precedent set forth in Sections 3(a)
and (b) of this letter amendment, in accordance with the terms thereof, the Credit Agreement is hereby amended by deleting clause (b) of Section 7.9 of the Credit Agreement in its entirety, and by substituting in lieu
thereof the following new clause (b): 
 (b) to sell, assign, lease, or otherwise dispose of all or any part of
its property at any time except that any Credit Party may sell, assign, lease or otherwise dispose of all or any part of its property so long as, immediately before and after giving pro forma effect to each such sale, assignment, lease, or
disposition, Credit Parties have Availability in an amount equal to or greater than the greater of (i) 15% of the amount of 

  
 - 2 -

 
the Commitments, and (ii) $15,000,000 on the date of such sale, assignment, lease or disposition. All net proceeds of any sale, assignment or other disposition shall be applied to repayment
of the Obligations without a corresponding reduction of the Commitments. 
 2. Release of Clinical Research, Clinical
Research Flex, KCR Canada, and KCR Puerto Rico as Credit Parties. 
 (a) Upon the satisfaction of each condition
precedent set forth in Section 3 of this letter amendment in accordance with the terms thereof (the “Effective Release Date”), and in furtherance of the foregoing and without further action by any party hereto,
(i) Administrative Agent, Lenders, and Credit Parties hereby acknowledge and agree that each of Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico shall no longer be deemed to be, and shall not have any of the rights of,
a “Borrower” or a “Credit Party” under the Credit Agreement and the other Loan Documents to which Clinical Research, Clinical Research Flex, KCR Canada, or KCR Puerto Rico, as applicable, is a party, (ii) each Lender hereby
authorizes Administrative Agent to release its Liens in all of the Released Assets, and (iii) Administrative Agent and Lenders hereby release and discharge each of Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico from
all liability with respect to the Obligations and from any and all other obligations, covenants and liabilities under the Credit Agreement and the other Loan Documents. For the avoidance of doubt, each Credit Party acknowledges and agrees that
Administrative Agent’s Liens and security interests shall continue in the Sale Proceeds. Each Credit Party represents and warrants to Administrative Agent and Lenders that, other than the Liens of Administrative Agent to secure the Obligations,
the Released Assets are not subject to any Lien or claim that would require any Credit Party under Applicable Law or any agreement to make any payment or deliver any portion of the Sale Proceeds to any Person other than Administrative Agent in order
to transfer and convey such assets to Purchaser free and clear of Liens. 
 (b) Upon the satisfaction of each condition
precedent set forth in Section 3 of this letter amendment in accordance with the terms thereof, and in furtherance of the foregoing, Administrative Agent agrees to deliver to Purchaser all certificates evidencing Capital Stock included
in the Released Assets, and to file, at Credit Parties’ expense, UCC termination statements with respect to Administrative Agent’s UCC financing statements filed against each of Clinical Research, Clinical Research Flex, KCR Canada, and
KCR Puerto Rico. Except for Administrative Agent’s release of its Lien upon the Released Assets described above, Administrative Agent shall retain all of its Liens upon all other Collateral (including, without limitation, the Sale Proceeds),
and nothing contained herein shall be deemed or construed to create a novation or accord and satisfaction, and the Credit Agreement and the other Loan Documents shall remain in full force and effect with respect to all Credit Parties other than
Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico (each such Credit Party other than Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico being hereinafter referred to individually as a
“Continuing Credit Party” and collectively as “Continuing Credit Parties”. Each Continuing Credit Party, Administrative Agent and each Lender acknowledge and agree that, after giving effect to the provisions of this
letter amendment (including, without limitation, the foregoing provisions of this section), each Continuing Credit Party shall remain jointly and severally liable for all of the Obligations, whether arising prior to, on, or after the Effective
Release Date, including, without limitation, the Obligations of each of Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico arising prior to the Effective Release Date, and, for the avoidance of doubt, all indemnification
obligations that may arise on or after the Effective Release Date in respect of any act or failure to act on the part of Clinical Research, Clinical Research Flex, KCR Canada, or KCR Puerto Rico prior to the Effective Release Date. 

(c) For the avoidance of doubt, each Continuing Credit Party hereby (i) consents to the release of each of Clinical Research,
Clinical Research Flex, KCR Canada, and KCR Puerto Rico as a 

  
 - 3 -

 
“Borrower” and a “Credit Party” under the Credit Agreement and the other Loan Documents, and (ii) acknowledges and agrees that (A) neither such release nor anything
contained in this letter amendment shall modify in any respect whatsoever such Continuing Credit Party’s Obligations, covenants, duties, indebtedness and liabilities as a “Borrower” or a “Guarantor”, as applicable, and
“Credit Party” under the Credit Agreement and the other Loan Documents, all of which are hereby ratified, reaffirmed and shall remain in full force and effect, (B) the Credit Agreement and the other Loan Documents to which such
Continuing Credit Party is a party are the legal, valid and binding obligations of such Continuing Credit Party that are enforceable against such Continuing Credit Party in accordance with the terms thereof, and (C) all security interests and
Liens granted to or for the benefit of Administrative Agent, and all security interests and Liens upon the Collateral (other than the Released Assets) granted to Administrative Agent pursuant to the Credit Agreement and the other Loan Documents
remain in full force and effect and secure all Obligations of each Continuing Credit Party under the Credit Agreement and the other Loan Documents, all of which are hereby ratified and confirmed. 

3. Conditions Precedent. The effectiveness of Sections 1 and 2 of this letter amendment shall be subject to
the satisfaction of the following conditions precedent, in form and substance satisfactory to Administrative Agent (as determined by Administrative Agent in its sole discretion), on or before March 31, 2012: 

(a) Administrative Agent shall have received an original signed counterpart to this letter amendment from each Lender and
each Credit Party; 
 (b) Administrative Agent shall have received true, correct, and complete copies of
resolutions for each Credit Party that authorize such Credit Party to enter into this letter amendment; 
 (c)
Administrative Agent shall have received the Sale Proceeds, up to the aggregate outstanding amount of the Obligations as of the consummation of the closing under the Sale Documents, in immediately available funds and in accordance with the following
wiring instructions: 
  

			
		  	Account Name: Kforce
		  	Account #: 003667400189
		  	Routing # (ABA): 0260-0959-3
		  	SWIFT Code: BOFAUS3N
		  	Bank: Bank of America
		  	Address: 100 West 33rd Street, New York, NY 10001

 (d) Administrative Agent shall have received true, correct, and complete copies of the
Sale Documents; 
 (e) Administrative Agent shall have received from (i) Kforce an original signed
counterpart to the Collateral Assignment of Rights and Sums Due Under Stock Purchase Documents, in substantially the form attached hereto as Exhibit B, and (ii) Purchaser an original signed counterpart to the Acknowledgement of
Collateral Assignment of Rights and Sums Due Under Stock Purchase Documents, in substantially the form attached hereto as Exhibit C; 
 (f) Administrative Agent shall have received a Certificate Regarding Release of Credit Parties made by each Credit Party in favor of Administrative Agent and Lenders in the form attached hereto as
Exhibit D; and 

  
 - 4 -

 (g) Administrative Agent shall have received from each Borrower (other than
Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico) an amended and restated Revolving Loan Note for each Lender, in the form attached hereto as Exhibit E. 

4. Form of Release. Upon the satisfaction of each condition precedent set forth in Section 3 above in
accordance with the terms thereof, Administrative Agent’s release of its Lien upon the Released Assets shall be effected by the release documents attached to this letter amendment as Exhibit F. Credit Parties and Purchaser shall assume
sole responsibility for recording such partial release documents, as applicable, and all fees, costs, and taxes associated with such recordings. 
 5. Expense Reimbursement. Credit Parties shall promptly reimburse Administrative Agent for all costs and expenses (including, without limitation, legal fees and
expenses) incurred by Administrative Agent in connection with the preparation, documentation, and negotiation of this letter amendment and the exhibits hereto and the consummation of the transactions herein described. 

6. Release of Claims. To induce Administrative Agent and Lenders to enter into this letter amendment, each Credit Party
(including, without limitation, Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico) hereby releases, acquits and forever discharges Administrative Agent and Lenders, and all officers, directors, agents, employees, successors
and assigns of Administrative Agent and Lenders, from any and all liabilities, claims, demands, actions or causes of action of any kind or nature (if there be any), whether absolute or contingent, disputed or undisputed, at law or in equity, or
known or unknown, that such Credit Party now has or ever had against Administrative Agent or any Lender arising under or in connection with this letter amendment, the Credit Agreement, any of the other Loan Documents or otherwise. Each Credit Party
(including, without limitation, Clinical Research, Clinical Research Flex, KCR Canada, and KCR Puerto Rico) represents and warrants to Administrative Agent and Lenders that such Credit Party has not transferred or assigned to any Person any claim
that such Credit Party ever had or claimed to have against Administrative Agent or any Lender. 
 7. Waiver of Jury
Trial. Credit Parties, Lenders, and Administrative Agent each irrevocably waive their respective rights to a trial by jury of any claim or cause of action based upon or arising out of or related to this letter amendment or the
transactions contemplated hereby, in any action, proceeding or other litigation of any type brought by any of the parties hereto against any other party hereto. 
 [Document continues on following page.] 

  
 - 5 -

 8. Miscellaneous. If this letter amendment is acceptable to Credit Parties,
please evidence each Credit Party’s agreement with the terms hereof by executing and returning the enclosed copy of this letter amendment to Administrative Agent on or before March 30, 2012. By its signature below, each Credit Party agrees
that Administrative Agent’s Lien upon the Released Assets will not be released until all of the conditions to the release thereof have been fully satisfied, including, without limitation, Administrative Agent’s receipt of the Sale Proceeds
in accordance with Section 3 above and Administrative Agent shall have received a certificate in the form attached hereto as Exhibit D. This letter amendment may be executed in any number of counterparts and by different parties
to this letter amendment on separate counterparts, each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute one and the same agreement. Any manually executed signature page to this letter amendment
delivered by a party by facsimile or other electronic transmission shall be deemed to be an original signature hereto. This letter amendment shall be governed by and construed in accordance with the internal laws of the State of Georgia. This letter
amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. Section titles and references used in this letter amendment shall be without substantive meaning or content of any kind
whatsoever and are not a part of the agreements among the parties hereto. 
  

			
	Very truly yours,
	
	BANK OF AMERICA, N.A., as Administrative Agent
	(“Administrative Agent”)
		
	By:	 	 /s/ Andrew A. Doherty

		 	Andrew A. Doherty, Senior Vice President
	
	BANK OF AMERICA, N.A., as a Lender
	(“Lender”)
		
	By:	 	 /s/ Andrew A. Doherty

		 	Andrew A. Doherty, Senior Vice President

 [Signatures continue on following page.] 

 Acknowledged and agreed to: 

 

			
	WELLS FARGO BANK, NATIONAL ASSOCIATION
	(“Lender”)

			
		
	By:	 	 /s/ Lynn Culbreath

	Name:	 	 Lynn Culbreath

	Title:	 	 Senior Vice President

 [Signatures continue on following page.] 

			
	JPMORGAN CHASE BANK, N.A.
	(“Lender”)

			
		
	By:	 	 /s/ Kevin Harrison

	Name:	 	 Kevin Harrison

	Title:	 	 Regional Portfolio Manager

 [Signatures continue on following page.] 

			
	KFORCE INC.
	KFORCE GOVERNMENT SOLUTIONS, INC.
	KFORCE CLINICAL RESEARCH, INC.
	KFORCE CLINICAL RESEARCH FLEX, LLC
	KFORCE HEALTHCARE, INC.
	KFORCE HEALTHCARE FLEX, LLC
	KCR CANADA, INC.
	KCR PUERTO RICO, LLC
	KFORCE AIRLINES, INC.
	KFORCE.COM, INC.
	KFORCE FLEXIBLE SOLUTIONS, LLC
	KFORCE GOVERNMENT HOLDINGS INC.
	KFORCE STAFFING SOLUTIONS OF CALIFORNIA, LLC
	KFORCE GLOBAL SOLUTIONS, INC.
	ROMAC INTERNATIONAL, INC.
	KFORCE SERVICES CORP.
	(“Credit Parties”)
		
	By:	 	 /s/ Judy M. Genshino-Kelly

		 	Judy M. Genshino-Kelly, Vice President and Treasurer

 EXHIBIT A 

Stock Purchase Agreement 

 EXHIBIT B 

Collateral Assignment of Rights and Sums Due Under Stock Purchase Documents 

 EXHIBIT C 

Acknowledgement of Collateral Assignment of 
 Rights and Sums Due Under Stock Purchase Documents 

 EXHIBIT D 

Certificate Regarding Release of Credit Parties 

 EXHIBIT E 

Amended and Restated Revolving Loan Notes 

 EXHIBIT F 

Release DocumentsAmended Administrative Agreement

 Exhibit 10.3 
 BEFORE THE UNITED STATES DEPARTMENT OF THE INTERIOR 
  

			
	In the matters of:	 	
		
	Kforce Government Solutions, Inc.	 	Case No. AIU-EV-BLM-0036-2009
		
	Kforce Global Solutions, Inc.	 	Case No. AIU-EV-BLM-0041-2009
		
	Bradson Corporation	 	Case No. AIU-EV-BLM-0043-2009

 AMENDED ADMINISTRATIVE AGREEMENT 

This Amended Administrative Agreement (“Amended Agreement”) is entered into and is effective on May 3, 2012, between and
among Kforce Government Solutions, Inc., (hereinafter “KGS” or “the Company”) and the U.S. Department of the Interior (“DOI”). This Amended Agreement supersedes the original administrative agreement (“Original
Agreement”) dated December 29, 2009, between the above parties. 
 I. PREAMBLE 

A. KGS assists Federal agencies with solutions and services in information technology, finance and accounting, healthcare informatics,
intelligence, Data Confidence, and business transformation. KGS’s customers include United States Government agencies and instrumentalities, and KGS supports U.S. military operations in various locations around the world. 

B. In 2006-2007, KGS merged with Bradson Corporation, an established provider of services to Federal agencies in finance and accounting,
program management and performance management. 
 C. Kforce Global Solutions, Inc. is a sister company of KGS; both companies
are owned by Kforce Government Holdings, Inc. KGS represents that Kforce Global Solutions, Inc. does not engage in Federal Government contracting. Kforce, Inc. is the parent company of all of the above-named companies. 

D. On December 18, 2009, KGS, Kforce Global Solutions, Inc., and Bradson Corporation received notices of proposed debarment from the
DOI. 

  
 1 

 E. The DOI proposed to debar KGS based on the actions of Thomas Denneny, a Senior Vice
President of KGS, who prepared a Statement of Work (“SOW”) in 2008 that subsequently became the basis for Bureau of Land Management (“BLM”) Task Order No. PAD086083. Mr. Denneny prepared the SOW in the absence of a contract
with BLM for that work. The DOI also based the action on the fact that KGS subsequently bid on and was awarded the BLM task order in violation of 48 C.F.R. § 9.505-2(a)(1). The Task Order was for a fixed price of $78,892.32. 

F. The DOI also proposed to debar Mr. Denneny based on these actions. 

G. The DOI proposed to debar Kforce Global Solutions, Inc. and Bradson Corporation as affiliates of KGS. 

H. In or about January, 2009, KGS became aware that the DOI Office of Inspector General (“DOI OIG”) was conducting an
investigation into the Task Order. KGS responded cooperatively with that investigation. It produced documents and made its personnel, including Mr. Denneny, available for interviews in February, 2009 and again in September, 2009.

 I. After receiving the notice of proposed debarment, KGS represents that it suspended Mr. Denneny the next business day,
December 21, 2009, pending the outcome of these proceedings. 
 J. In order to assure the DOI of its present responsibility
as a Federal Government contractor, KGS agrees to take the remedial actions specified in this Amended Agreement. 
 K. The DOI
has determined that, in light of all the facts and circumstances now available, including the information provided by KGS in response to the notices of proposed debarment regarding actions taken and additional actions agreed to be undertaken by KGS
as specified in the terms and conditions of this Amended Agreement, adequate assurance exists that KGS will conduct its future dealings with the Federal Government with the high degree of honesty and integrity required of a Federal Government
contractor or non-procurement program participant and that debarment of KGS is not necessary at this time to protect Federal Government interests. 
 NOW THEREFORE, the parties agree as follows: 
 II. TERMS and
CONDITIONS 
 1. Effective Date and Term. The Effective Date of this Amended Agreement is May 3, 2012, and
is effective through September 30, 2013. Prior to September 30, 2013, DOI will evaluate KGS’s compliance with the terms of this Amended Agreement. 
 2. Termination of Proposed Debarment of KGS and Affiliated Companies. Effective upon the execution of the Original Agreement, the proposed debarment of KGS, Kforce Global Solutions, Inc., and
Bradson Corporation were terminated by the Suspending and Debarring Official. 

  
 2 

 3. Employment of Thomas Denneny. Thomas Denneny is no longer employed by KGS.

 4. Refund Profits from the Contract. The Company refunded to the DOI all profits from the Task Order. 

5. Compliance and Ethics Program. KGS agreed to enhance its existing compliance and ethics program. Specifically, KGS employed an
outside contractor, approved by the DOI, to conduct full-day training sessions on laws and regulations applicable to Federal Government contractors. KGS agreed that these training sessions would be attended by all KGS managers and employees involved
in the procurement or management of federally funded work. Other employees directly or indirectly performing services in connection with federally funded work would receive appropriate training on the KGS Ethics and Compliance Program. In addition,
KGS conducted special, supplementary training in January 2010 on procurement integrity and conflicts of interest, and thereafter will conduct quarterly seminars focused primarily on the compliance aspects of Federal contracting. These supplementary
training sessions will be attended by all KGS managers and employees involved in the procurement or management of federally funded work. KGS will continue its practice of distributing its corporate ethics and procurement integrity policy (or any
updates thereto) to all employees and managers and require that each of its employees and managers certify that he or she (i) has received a copy of the policy, and (ii) has been advised that compliance with the policy is a condition of
continued KGS employment (to the extent permitted by law). All newly hired employees and managers shall receive compliance and ethics program training (which may be tailored to their function) within sixty (60) days of the commencement of their
employment with KGS. The Company will also include compliance with the ethics and procurement integrity policy as an element of the KGS annual manager and employee performance review. Within ten (10) business days of the Effective Date of the
Original Agreement, KGS submitted a training schedule to the DOI and DOI OIG setting forth the dates for the supplementary and quarterly training referenced above, the level of responsibility of the managers and employees who would be trained, and
where the training would take place. 
 6. Risk Assessment and Work Plan. KGS agrees to retain Global Compliance Services
to conduct a Risk Assessment to identify and prioritize KGS’s major ethics and compliance risks. Global Compliance Services may make recommendations to strengthen and adapt the existing Compliance and Ethics Plan to address these risks. KGS
will revise its existing Compliance and Ethics Plan as appropriate to address the recommendations. KGS will share any revised Compliance and Ethics Plan with DOI and DOI OIG. KGS will encourage Global Compliance Services to consult with the
Third-Party Monitor to the extent practicable so that Global Compliance Services may avail itself of the Third-Party Monitor’s experience in working with KGS concerning these matters. 

7. Hotline. KGS will implement a toll-free, dedicated hotline to report suspected misconduct relating to Federal procurements. KGS
will publicize the toll-free number of its 

  
 3 

 
hotline to all of its employees. KGS will not permit retaliation against those who report suspected misconduct and will advise its employees of this policy. KGS will publicize to all of its
employees the FAR Mandatory Disclosure Rule, which requires Federal Government contractors to timely disclose to the contracting agency’s Office of Inspector General (providing a copy to the contracting officer) whenever, in connection with the
award, performance, or closeout of a Federal Government contract, the contractor has credible evidence that a principal, employee, agent, or subcontractor has committed a violation of Federal criminal law involving fraud, conflict of interest,
bribery, or improper gratuity violations found in Title 18 of the United States Code, or a violation of the False Claims Act found at 31 U.S.C. §§ 3729-3733. 
 8. OIG Fraud Awareness Training. KGS agrees to permit DOI OIG to conduct fraud awareness training at KGS as necessary for the duration of this Amended Agreement. These training sessions will be
attended by all KGS managers and employees involved in the procurement or management of federally funded work. This training will be provided at no cost to KGS. 
 9. Compliance Officer. KGS appointed a new Compliance Officer. The Compliance Officer is the Federal Services Counsel of Kforce, Inc., who reports directly to the General Counsel of Kforce, Inc.
The Compliance Officer is responsible for monitoring compliance with (i) the Corporate Ethics and Procurement Integrity Policy and (ii) this Amended Agreement. The Compliance Officer will maintain a confidential record that identifies all
contacts made to the toll-free hotline and all matters reported to the Compliance Officer. The record will include, at a minimum, the nature of the reported conduct, the results of the internal investigation, and any corrective action taken by KGS.
The Compliance Officer will report to the Board of Directors, at least twice a year, concerning the compliance program and the Company’s adherence to this Amended Agreement. The Compliance Officer will be available to the DOI or DOI OIG to
respond to inquiries with regard to KGS’s compliance with the Corporate Ethics and Procurement Integrity Policy and any of the requirements of this Amended Agreement. 
 To ensure that the Compliance Officer is integrated into the KGS organization, the Compliance Officer will establish a permanent office in the KGS Fairfax, Virginia Headquarter Offices. The Compliance
Officer will be added as a regular attendee of weekly management meetings, town-hall style meetings, and Board of Director meetings. The Compliance Officer will also schedule regularly occurring meetings with Executive Leadership to ensure the
Compliance Officer has current insight into the Company’s strategy and operations. In addition, the Compliance Officer will: 1) continue to participate as a presenter at all quarterly compliance training; 2) serve as the Chairperson of the
Compliance Steering Committee; and 3) continue to regularly participate in Deal Review Board sessions or in any sessions that perform the same function as the current Deal Review Board. Also, KGS will create the role of Deputy Compliance Officer in
the KGS Contracts Department to provide the Compliance Officer with a point of contact with the daily operations of KGS, as well as additional compliance support. 
 10. KGS Board of Directors Compliance Committee. The KGS Board of Directors will establish a Compliance Committee, which will adopt a written Charter setting forth its role and responsibilities.

  
 4 

 11. Non-Retaliation Policy. KGS will assess the impact on other KGS employees, if
any, of the termination of an associate in the Research and Development Division in April, 2011. KGS will reinforce its non-retaliation and related policies by reviewing the existing policies, including non-retaliation as a topic in the quarterly
compliance training required by this Amended Agreement, and communications from KGS leadership to all KGS employees. KGS will audit and monitor the existence and impact of any reported or identified retaliation and incorporate these procedures into
KGS’s Annual Compliance Work Plan. 
 12. Reporting. KGS will submit a semi-annual written report to the DOI
Suspending and Debarring Official and DOI OIG. In each report, KGS will describe the measures it has taken to comply with this Amended Agreement. Each report shall include: 

 

	 	(i)	Compliance and ethics training conducted and the number of persons who attended; 

 

	 	(ii)	Informal notifications or initiatives related to the compliance program; 

  

	 	(iii)	Any significant changes in the directives, instructions, or procedures implemented in furtherance of KGS’s Corporate Ethics and Procurement Integrity Policy, or
any successor policy; 

  

	 	(iv)	The status of any Federal or state investigation or audit of KGS’s own conduct or conduct by its principals, employees and/or former employees that might be
imputed to KGS, and legal proceedings resulting in search warrants, subpoenas, criminal charges, or civil agreements; 

  

	 	(v)	A listing of Federal Government audits and related actions (routine or otherwise) during the period; 

 

	 	(vi)	A report summarizing all contacts made to the hotline, and all other instances of misconduct reported to the Compliance Officer. The report will include, at a minimum,
the nature of the reported or suspected misconduct, the results of the internal investigation, and any corrective action taken by the Company. Subject to the attorney-client privilege and reporting party confidentiality, details on each case will be
made available to the DOI and DOI OIG upon request; and 

  

	 	(vii)	Any other information required by this Amended Agreement. 

 13. Third-Party Monitor. KGS hired an independent third-party monitor mutually agreed upon by KGS and the DOI. The Third-Party Monitor will monitor KGS’s compliance with the terms of this
Amended Agreement and will be engaged by KGS for the duration of this Amended Agreement. As reasonably necessary for the purpose of verifying and evaluating KGS’s compliance with the terms of this Amended Agreement, the Third-Party Monitor will
examine KGS’s books, records, and other documents and supporting materials. Such materials will be made available by KGS during normal business hours for inspection and review. For 

  
 5 

 
purposes of this paragraph, the Third-Party Monitor may interview any KGS employee or manager who consents to be interviewed, at the employee’s or manager’s place of business during
normal business hours or at such other place and time as may be mutually agreed between the employee or manager and the Third-Party Monitor. The Third-Party Monitor will make semi-annual reports to the DOI, DOI OIG, and KGS to verify KGS’s
compliance with the terms of this Amended Agreement. The Third-Party Monitor will also make other reports to DOI, DOI OIG, and KGS as necessary and/or be available to respond to inquiries as necessary. 

14. Documentation. KGS will maintain documentation sufficient to demonstrate compliance with the requirements of this Amended
Agreement. 
 15. Government Investigations and Audits. In addition to the periodic written reports required under
paragraph 12, KGS will notify the DOI and DOI OIG within five (5) business days of the time KGS learns of (a) the initiation of any criminal or civil investigation into KGS’s conduct by any Federal or state governmental entity;
(b) the service of subpoenas on KGS that relates to KGS as a Federal contractor; (c) the service of search warrants on and/or searches of KGS and locations under its control; (d) the criminal indictment of KGS or any of its officers;
and (e) the initiation of any non-routine audit of KGS by any Federal agency (for example, routine Defense Contract Audit Agency audits need not be reported under this paragraph). 

16. Similar Misconduct. If, during the course of this Amended Agreement, KGS learns that the employee misconduct or similar
misconduct that occurred on the BLM procurement referenced in paragraph E above also occurred on other Federal contracts or non-procurement transactions, KGS will promptly notify the Suspending and Debarring Official as well as the applicable
agency’s Office of Inspector General, or responsible investigating authority, of the discovery. KGS performed an inquiry to determine if Mr. Denneny, or any other KGS employee, engaged in any similar activity in violation of 48 C.F.R.
§ 9.505-2(a)(1), with any BLM employee, to include Ms. Betty Buxton, in the award of any prior contracts, to include the award of a contract involving the Southern Nevada Public Land Management Act. KGS provided a report to the Suspending
and Debarring Official and DOI OIG within three (3) months from the Effective Date of the Original Agreement, concerning the actions taken in order to perform this inquiry and the results of the inquiry. 

17. Employment of Excluded Parties. KGS will develop an internal policy that the Company will not knowingly hire an individual who
is suspended or debarred or otherwise declared ineligible for Federal programs to work as an agent, representative, or principal, including being a key employee, for purpose of the performance of any Federal procurement and non-procurement award. In
order to carry out the policy, KGS will review the Excluded Parties List System (http://www.epls.gov) in connection with any new hire. 
 18. Release. KGS hereby releases the DOI, its agents and employees in their official and personal capacities of any and all liability or claims arising out of or related to the DOI OIG
investigation, the notice of proposed debarment, and this Amended Agreement. 
 19. Unallowable Costs. All costs defined
in FAR § 31.205-47 incurred by or on behalf of KGS in performance of this Agreement, or associated with the monitoring of this 

  
 6 

 
Agreement by the Third-Party Monitor, and all costs incurred by KGS in negotiating, implementing, and abiding by the terms of this Agreement, other than the costs associated with KGS’s
Compliance and Ethics Program, will be deemed unallowable costs, whether direct or indirect, for Federal Government contract purposes. In addition, all costs associated with the performance of BLM Task Order PAD086083 will be deemed unallowable
costs. KGS agrees to account for these unallowable amounts separately by identifying any such costs incurred through (i) accounting records to the extent possible; (ii) memoranda, including diaries and logs, regardless of whether such
records are part of official Company documentation where accounting records are not available; or (iii) through good-faith itemized estimates where no other accounting basis is available. 

20. Successors and Assigns. The terms, conditions, and obligations of this Amended Agreement will survive the reorganization of
KGS’s corporate structure and will be fully binding upon any organization which is a successor in interest or an assignee to substantially all of the assets or shares of KGS. The Successor or Purchaser may request that the Suspending and
Debarring Official review the need for continuation of the terms and obligations of this Amended Agreement. 
 21.
Implementation by KGS. KGS will implement all provisions of this Amended Agreement including its Ethics and Compliance Conduct Program with respect to any business that KGS acquires or establishes after the Effective Date of this Amended
Agreement, within sixty (60) calendar days following completion of such acquisition or establishment. 
 22. Cooperation
by KGS. When requested, KGS will cooperate fully with any investigation of suspected wrongdoing involving KGS’s operations or activities and will encourage present and past employees of KGS to make a full and candid disclosure of their
personal knowledge of the facts and circumstances of any suspected wrongdoing. 
 23. Representations. KGS represents
that all written materials and other information supplied to the DOI by the Company’s authorized representatives during the course of discussions preceding this Amended Agreement are true and accurate to the best information and belief of the
KGS signatory to this Amended Agreement. KGS understands that this Amended Agreement is executed on behalf of the DOI in reliance upon the truth and accuracy of all such representations. 

24. No Waiver. Nothing in this Amended Agreement limits the DOI or any other Federal agency from initiating administrative
actions, including suspension or debarment, should information indicating the propriety of such action come to the attention of the DOI Suspending and Debarring Official or any other Federal agency. 

25. Breach. KGS and the DOI agree that the causes for debarment survive the execution of this Amended Agreement, and the DOI may
initiate debarment proceedings against KGS on these grounds if there is a material breach of this Amended Agreement. KGS and the DOI agree that repeated violations of non-material provisions of this Amended Agreement may cumulatively become a
material breach of this Amended Agreement. The DOI’s Suspending and Debarring Official will provide written notice to KGS of any alleged failure to meet its material 

  
 7 

 
obligations under the terms of this Amended Agreement. If KGS fails to submit an acceptable plan of corrective action to the Suspending and Debarring Official within fifteen (15) calendar
days of receipt of such notice, or as otherwise permitted by the Suspending and Debarring Official, the DOI may initiate debarment proceedings against KGS and any affiliates. 
 26. DELETED. 
 27. Entire Amended Agreement. This Amended Agreement
constitutes the entire agreement between the parties and supersedes all prior agreements and understandings, whether oral or written, related to the subject matter hereof. 
 28. Authority of the United States. The provisions of this Amended Agreement in no way alter or diminish the rights and responsibilities of the United States to carry out its lawful functions in
any proper manner. 
 29. Authorized Signatories. The signatory of each party is fully authorized to execute this Amended
Agreement and represents that he or she has the authority to bind the DOI or KGS, respectively. 
 30. Severability. In
the event that any one or more of the provisions contained in this Amended Agreement will for any reason be held to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability, will not affect other
provisions of this Amended Agreement. 
 31. Notices. Any notices or information required hereunder will be in writing
and delivered by facsimile with receipt or mailed by registered or certified mail, postage prepaid, as follows: 
  

					
		 	If to KGS, to:	  	Larry Grant
		 		  	President
		 		  	Kforce Government Solutions, Inc.
		 		  	2750 Prosperity Avenue
		 		  	Suite 300
		 		  	Fairfax, VA 22031
			
	and	 		  	
		 		  	William S. Josey
		 		  	General Counsel
		 		  	Kforce, Inc.
		 		  	1001 East Palm Avenue
		 		  	Tampa, FL 33605
			
		 	If to the DOI, to:	  	Debra E. Sonderman, Director
		 		  	Office of Acquisition and Property Management
		 		  	U.S. Department of the Interior
		 		  	1849 C Street, NW
		 		  	Washington, DC 20240

  
 8 

					
			
	and    	 		  	
		 		  	Stanley Stocker, Debarment Program Manager
		 		  	Recovery Oversight Office
		 		  	Office of Inspector General
		 		  	U.S. Department of the Interior
		 		  	1849 C Street, NW
		 		  	Washington, DC 20240

 Or such other address as any party will have designated by notice in writing to the other party. 

32. Public Document. This Amended Agreement, including all attachments, is a public document. 

33. Contractor Past Performance Databases. DOI reserves the right to include the information concerning the misconduct that served
as the basis for the proposed debarment of KGS in any Federal Government database concerning contractor past performance, for example, the Past Performance Information Retrieval System. 

34. Headings. Section and paragraph headings are intended for the convenience of the parties and are not to be used to interpret
this Amended Agreement. 
 35. Amendment. This Amended Agreement may be amended or modified only by a written document
signed by both parties. 
 36. Certification. By signature hereto, the individual executing this Amended Agreement on
behalf of KGS certifies that he understands that the provisions of 18 U.S.C. § 1001 are applicable to the statements and representations contained herein. 
 37. Execution. This Amended Agreement may be executed in counterparts which, taken together, will have the same force and effect as a single instrument, and executed copies may be delivered
electronically or via facsimile, with originals to follow as soon as practicable. 

  
 9 

			
	KFORCE GOVERNMENT SOLUTIONS, INC.
		
	By:	 	 /s/ Larry Grant

		 	Larry Grant
	Title:	 	President
		 	Kforce Government Solutions, Inc.
		
	Dated:	 	April 27, 2012
	
	KFORCE, INC. as to Paragraph 9
		
	By:	 	 /s/ David L. Dunkel

		 	David L. Dunkel
	Title:	 	Chief Executive Officer
		 	Kforce, Inc.
		
	Dated:	 	April 27, 2012
	
	U.S. DEPARTMENT OF THE INTERIOR
		
	By:	 	 /s/ Debra E. Sonderman

		 	Debra E. Sonderman
	Title:	 	Director
		 	Office of Acquisition and Property Management
		
	Dated:	 	May 3, 2012

  
 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}]]